Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Spinal Cord Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Optic Nerve Glioma 1Medulloblastoma 1Familial ependymoma 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Astrocytoma 1AIDS-related Kaposi sarcoma 1

Interventions

Carboplatin 3Vincristine 2Psychiatric Rehabilitation 2Irinotecan 2lonafarnib 1laromustine 1imetelstat 1emvododstat 1Vinblastine 1Valproic Acid 1Topotecan 1Thrombopoietin 1Thioguanine 1Temozolomide 1Semaxinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Procarbazine 1N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine 1Lomustine 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Drug Therapy 1Busulfan 13-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Optic Nerve Glioma × Valproic Acid × Clear all
NCT00107458 2014-08-07

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Children's Oncology Group

Phase 1 Completed
26 enrolled
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡